HLC Neonate

Basic Information

Product Label

Full Name: HLC Neonate

Brand: Pharmax none

Product Type: Non-Nutrient/Non-Botanical

Physical State: Powder

UPC/SKU: 883196 20630

Status: Off Market

Product Version Code: Code PB10-6 V1.1

Contact Information

Made in the UK for

Name: Seroyal USA

Address:Pittsburgh, PA, 15275

Phone: 1-888-737-6925

Website: seroyal.com

Types: Distributor

Product Details

Net Contents

0.2 oz.(0.2 oz.)

6 Gram(s)(6 Gram(s))

Serving Sizes

Unit:Gram(s)

Quantity:0.1 - 0.1

Daily Servings:1 - 1

Notes:1 scoop

Target Groups

Children more than 1 but less than 4

Servings Per Container

Ingredients & Nutrition

Bifidobacterium animalis subsp. lactis (CUL-62)

bacteria

Group: Bifidobacterium animalis lactis

HLC Consortium

blend

Group: Blend (non-nutrient/non-botanical)

Lactose Monohydrate

sugar

Group: Lactose

UNII Code: EWQ57Q8I5X

Product Statements

Suggested/Recommended/Usage/Directions

Recommended intake: Children (1-4 years): Add one level scoop (100 mg) of HLC Neonate powder into a single day feeding of expressed breast or formula milk or as professionally directed. Take at least 2-3 hours before or after taking antibiotics.

Precautions re: All Other

Risk Information: If you have an immune-compromised condition, do not use. If you are experiencing nausea, fever, vomiting, bloody diarrhea or severe abdominal pain, consult your healthcare practitioner prior to use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner.

Precautions re: All Other

Vacuum-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken.

Storage

Store under refrigeration (below 46(0) F).

FDA Statement of Identity

Probiotic Supplement

Seals/Symbols

Contains Clinically Proven Strains

Formulation re: Does NOT Contain

Gluten Free and FOS Free

General Statements: All Other Content

Human Lactic Commensals (HLC) probiotic strains are research-driven and clinically proven in randomized, double-blind, placebo-controlled human trials at 25 billion CFU per day. Proprietary non-pathogenic human-sourced microflora bacterial strains are utilized as they have strong epithelial adherence and a naturally high tolerance to stomach acid.